Lanean...
Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma
Portal vein embolization (PVE) for hepatocellular carcinoma (HCC) was first introduced in 1986 and has been continuously developed throughout the years. Basically, PVE has been applied to expand the indication of liver resection for HCC patients of insufficient future liver remnant. Importantly, PVE...
Gorde:
| Argitaratua izan da: | Ann Gastroenterol Surg |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8164464/ https://ncbi.nlm.nih.gov/pubmed/34095718 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ags3.12414 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|